Breeze Meds vs Hims: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hims beats Breeze Meds overall, scoring 7.9/10 vs 7.3/10. Hims is more affordable at $175/mo vs $199/mo. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose Hims for men who want glp-1 access from a well-known, publicly traded.
A side-by-side comparison of Breeze Meds and Hims covering pricing, scores, medication types, insurance, and more to help you decide.
Breeze Meds
#29 of 40Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsHims
#12 of 40One of the largest and most recognized men's telehealth platforms in the US, offering compounded GLP-1 medications with a polished app experience and strong brand trust.
Visit Hims| Feature | Breeze Meds | Hims |
|---|---|---|
| Our Score | 7.3/10 | 7.9/10 |
| Starting Price | $199/mo | $175/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a straightforward compounded GLP-1 program with fast shipping | Men who want GLP-1 access from a well-known, publicly traded telehealth brand |
| Ranking | #29 | #12 |
Pros & Cons Compared
Breeze Meds
Pros
- +No subscription required — order on demand without recurring billing commitments
- +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
Cons
- −Very limited independent reviews and unclear company structure — legitimacy is hard to verify
- −Oral options at $299-399/mo are significantly more expensive than injectable alternatives
- −Not available in all 50 states — varies by provider licensure in your state
Hims
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Polished app and web experience — one of the best user interfaces in men's telehealth
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Massive brand recognition and extensive customer support infrastructure
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Our Verdict
Hims edges out Breeze Meds with a score of 7.9/10 vs 7.3/10. If budget is your priority, Hims starts at $175/mo compared to Breeze Meds's $199/mo. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose Hims if you want: men who want glp-1 access from a well-known, publicly traded telehealth brand.